{"id":6260,"date":"2014-12-10T11:32:40","date_gmt":"2014-12-10T10:32:40","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=6260"},"modified":"2014-12-17T11:49:56","modified_gmt":"2014-12-17T10:49:56","slug":"germania-ritirati-dal-commercio-80-farmaci-generici","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/germania-ritirati-dal-commercio-80-farmaci-generici\/","title":{"rendered":"Germany: 80 generic drugs withdrawn from the market"},"content":{"rendered":"<p><i>Among the withdrawn generics are drugs for high blood pressure, migraine and depression<\/i><\/p>\n<p><a href=\"http:\/\/www.swissinfo.ch\/ita\/tutte-le-notizie-in-breve\/germania--ritirati-da-commercio-80-farmaci-generici\/41160540\" target=\"_blank\" rel=\"noopener\">09 DECEMBER 2014 \u2013 SWI swissinfo.ch<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"Government Site Builder Standardl\u00f6sung (Link zur Startseite)\" src=\"http:\/\/www.bfarm.de\/SiteGlobals\/StyleBundles\/Bilder\/Farbschema\/logo-bfarm.gif?__blob=normal&amp;v=4\" width=\"280\" height=\"45\" \/>In Germany, the federal drug regulatory authority has taken 80 generic pharmaceutical products from 16 companies off the market. This was announced by the same authority, motivating the decision with the recent scandal involving an Indian company responsible for the quality control of medicines, which turned out to be inadequate.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" alt=\"\" src=\"https:\/\/encrypted-tbn2.gstatic.com\/images?q=tbn:ANd9GcSjbMbRWO-K-ijAOToOE6p4TfqYIs5yzEustSQW_TNL_eM9deaAbA\" width=\"205\" height=\"156\" \/>Among the withdrawn generics are drugs for high blood pressure, migraine and depression. According to reports, at the moment there are no indications on any dangers for the population.<\/p>\n<p>sda-ats<\/p>\n<p><a href=\"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/stp-gvk-bioscience.html\" target=\"_blank\" rel=\"noopener\">The drug list<\/a><\/p>\n<p>Related news: <a href=\"http:\/\/www.fedaiisf.it\/en\/autorita-francesi-vietato-25-farmaci-generici-prodotti-in-india\/\" target=\"_blank\">French authorities have banned 25 generic medicines manufactured in India<\/a><\/p>\n<p><a href=\"http:\/\/www.fedaiisf.it\/en\/belgio-ritira-dal-commercio-farmaci-generici\/\">Belgium withdraws four generic medicines from the market<\/a><\/p>\n<p><a href=\"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/stp-gvk-bioscience.html\" target=\"_blank\" rel=\"noopener\">Arzneimittelzulassungen unter Verwendung von Studien der Firma GVK Biosciences in Indien: Ruhen der Zulassungen<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Tra i generici ritirati, ci sono farmaci contro la pressione alta, l&#8217;emicrania e la depressione 09 DICEMBRE 2014 \u2013 SWI swissinfo.ch In Germania l&#8217;autorit\u00e0 federale competente per la regolamentazione dei farmaci ha tolto dal commercio 80 prodotti farmaceutici generici di 16 aziende. Lo ha reso noto la stessa autorit\u00e0, motivando la decisione con il recente &hellip;<\/p>","protected":false},"author":4,"featured_media":6264,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[31],"class_list":["post-6260","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-generici"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/6260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=6260"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/6260\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/6264"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=6260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=6260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=6260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}